
GOVXD
Other · Other · $58,680 market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Mar 26, 2019 | Time not confirmed | — | -1.45 | — |
| Nov 8, 2018 | Time not confirmed | — | -1.99 | — |
| Aug 7, 2018 | Time not confirmed | — | -2.05 | — |
| May 3, 2018 | Time not confirmed | — | -2.50 | — |
| Mar 23, 2018 | Time not confirmed | — | -2.42 | — |
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform in the United States and internationally. It is developing various preventive vaccines against human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan,…